Unicycive Therapeutics

About:

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Website: https://unicycive.com/

Twitter/X: unicycive

Top Investors: RA Capital Management, Great Point Partners, Nantahala Capital Management, Vivo Capital, Walleye Capital

Description:

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs. It aims to open the way for a broad range of disease-modifying therapies by modifying the intracellular and extracellular concentrations of these various electrolytes and ions in Chronic Kidney Disease and Gitelman’s Syndrome and by addressing the underlying mitochondrial pathology and inflammation associated with Acute Kidney Disease. Unicycive Therapeutics was founded in 2016 and is headquartered in Los Altos, California.